Drug Database
LY

lysine salicylate (lysine salicylate / Dolorosan)

✓ Approved

VUFB · 小分子 · 小分子

什么是 lysine salicylate?

lysine salicylate 是一种小分子,由VUFB研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

商品名lysine salicylate, Dolorosan
公司VUFB
药物类别小分子
给药途径Unknown
状态Approved

治疗适应症

lysine salicylate 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Gastrointestinal disordersAbdominal pain✓ Approved

相关研究文献

PubMedTrends in genetics : TIG2026-11-19

Chromatin bivalency: canonical, noncanonical, and beyond.

Zhou Chengjie C, Zhang Yi Y

Chromatin bivalency, classically defined by the coexistence of histone H3 lysine 4 trimethylation and histone H3 lysine 27 trimethylation, has been proposed to maintain genes in a poised state, allowing them to remain transcriptionally repressed while retaining the potential for rapid activation. Recent studies have revealed that bivalent chromatin is established and resolved through distinct mechanisms across developmental contexts and can involve additional repressive modifications, including histone H2A lysine 119 monoubiquitination and histone H3 lysine 9 trimethylation. Functional perturbations further show that these modifications contribute unequally to transcriptional repression, suggesting that the classical two-mark model does not fully capture the regulatory complexity of bivalent chromatin. These findings extend the concept of bivalency toward chromatin polyvalency, in which multiple chromatin features coexist and contribute unequally to gene regulation. This review examines recent advances in the establishment, resolution, and function of bivalent chromatin in oogenesis, embryonic development, and hematopoiesis and discusses how noncanonical bivalency and chromatin polyvalency extend the classical bivalency framework.

PMID 43053506
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Lysine Side-Chain-to-Backbone Macroamidine Formation Reveals Activation-First YcaO Catalysis.

Fottner Maximilian M, Reichstein Julien J, Koehnke Jesko J, Vagstad Anna L AL

YcaO enzymes use ATP to modify chemically inert peptide-backbone amides, but the order of catalytic steps has remained unresolved. Here, we characterize a minimal Lysobacter ribosomally synthesized and post-translationally modified peptide (RiPP) pathway in which the stand-alone YcaO LmaB sequentially forms two lysine side-chain-to-backbone macroamidine linkages in the precursor peptide LmaA, revealing a previously unrecognized mode of YcaO-catalyzed peptide cyclization. Bioinformatic analyses place this pathway within a broader class of macroamidine-containing RiPPs, collectively termed macroamitides, which also includes the antibiotic bottromycins. High-resolution LmaB-LmaA structures directly resolve an O-phosphorylated peptide-backbone intermediate coordinated by ADP and three Mg2+ ions and capture the first macroamidine together with O-phosphorylation at the second reaction site. These snapshots reveal iterative substrate repositioning within a single active site. A structure of LmaB H75A retains the O-phosphorylated intermediate but traps the intact lysine nucleophile in a nonproductive conformation, identifying H75 as the general base that activates and positions the lysine ε-amino group for attack. Alanine scanning further reveals extensive tolerance of both ring-forming sequences. Together, these data establish that backbone O-phosphorylation precedes nucleophilic attack, revise the prevailing YcaO mechanism, and provide a model for engineering peptide-backbone chemistry during macroamidine formation.

PMID 43053390
阅读全文 →
PubMedJournal of translational medicine2026-11-19

Epigenetic 'language' of histone lysine: a promising target for macrophage-driven inflammation.

Wu Yu Y, Wang Wanying W, Yu Han H, Dai Yunfei Y et al.

Epigenetic modification in inflammation remains a frontier field with many unanswered questions. Macrophages, as the core cells that maintain tissue homeostasis and regulate inflammation, possess functional plasticity that enables their switching between pro‑inflammatory and anti‑inflammatory states. This plasticity is primarily regulated by epigenetic mechanisms. How histone lysine modifications, a core epigenetic regulatory mechanism, regulate the phenotypic transition of macrophages during inflammation therefore remains a key area of research. This review synthesizes current research on how histone lysine modifications, such as crotonylation, lactylation, ubiquitination, methylation, succinylation, and acetylation, act as key molecular switches to reshape chromatin architecture and regulate gene expression during macrophage activation. Furthermore, this review systematically delineates the mechanistic pathways through which these epigenetic changes coordinate inflammatory signaling cascades within complex regulatory networks. Deciphering this complex epigenetic 'language' provides a theoretical foundation and deeper insights into the therapeutic intervention of macrophage-driven inflammation, potentially leading to more precise treatment strategies for inflammatory diseases.

PMID 43053099
阅读全文 →
PubMedAnalytical and bioanalytical chemistry2026-11-19

Immunoprecipitation based on freely diffusing biotinylated-Protein A and avidin: protein purification in the absence of a polymer resin substrate.

Razi Syeed Ghulam SG, Krichevsky Olga O, Wachtel Ellen E, Patchornik Guy G

This study presents an immunoprecipitation protocol that eliminates the standard polymer resin and, by so doing, greatly improves target yield, purity and efficiency. The goal is achieved via the use of three non-immobilized protein components: (i) a specific IgG antibody; (ii) a synthesized, biotinylated Protein A (B-ProA); and (iii) unconjugated native avidin. The three proteins are added sequentially, without intervening incubation time, to an aqueous medium containing the target molecule. With bovine serum albumin (BSA) as the model target protein, along with polyclonal anti-BSA IgG, quantitative precipitation of BSA was achieved in the presence of an E. coli lysate protein background. BSA was extracted from the pellet containing [B-ProA:Avidin:Anti-BSA IgG] in NaCitrate buffer, pH 3, with >95% yield (by densitometry) and >96% purity (by SDS-PAGE). We found that these optimal results could be obtained when approx. 75% of the lysine amino acids of Protein A had been biotinylated, as determined by the ninhydrin test. High-resolution scanning transmission electron microscopy (HR-STEM) imaging of the [B-ProA:Avidin] complex revealed the formation of macro-assemblies with a variety of architectures. Even when comparison was made with commercial agarose-Protein A beads in the presence of E. coli lysate as background, or in the presence of human plasma, with or without IgG antibodies as background, the relative superiority of the [B-ProA:Avidin] matrix was apparent.

PMID 43052481
阅读全文 →
PubMedGenetics2026-11-19

Identity Crisis, Stonewall, and Putzig control the installation of a locus-specific H3K9me3 silencing domain essential for female germ cell identity in Drosophila.

Shapiro-Kulnane Laura L, Salz Helen K HK

Cell-type-specific gene silencing mediated by H3 lysine 9 trimethylation (H3K9me3)-marked chromatin is a conserved strategy for securing cell fate. In Drosophila germ cells, H3K9 methylation plays a crucial role in maintaining female identity by silencing testis-specific transcription of the PHD finger protein 7 (phf7) gene. However, the molecular mechanism underlying installation of this epigenetic mark remains poorly understood. Our prior work established that H3K9me3 installation requires the SETDB1 H3K9 methyltransferase and the DNA-binding protein Identity Crisis (IDC), a member of the ZAD-ZNF protein family. Here, we establish that the multifunctional DNA-binding protein Stonewall (STWL) is also essential for H3K9me3 deposition. Like IDC, STWL binds to chromatin within the first non-coding exon of phf7. To identify additional phf7 regulators, we leveraged mass spectrometry data on STWL- and IDC-associated proteins from ovarian lysates, prioritizing candidates enriched in both datasets. Notably, we observed enrichment of WINDEI (WDE), a required SETDB1 co-factor, suggesting that STWL and IDC may directly recruit SETDB1 to phf7 through their shared interaction with WDE. Another common interactor, the newly identified member of the ZAD-ZNF protein family called PUTZIG (PZG), also localizes to the first non-coding exon, where it promotes H3K9me3 deposition and silencing. Lastly, we show that PZG and IDC binding to the phf7 locus depends on the female sex-determination gene Sex-lethal. Collectively, our findings support a model in which IDC, STWL, and PZG, though individually insufficient, determine lineage choice by collectively producing a stable, locus-specific recruitment platform for H3K9me3 deposition in female but not male germ cells.

PMID 43053521
阅读全文 →
PubMedCancer cell international2026-11-19

AKR1B10 mediates glycolysis and proliferation in breast cancer via the IGF2R-PGK1-H4K12la-mTOR signaling axis.

Chen Shang S, Qiu Ailin A, Hu Qian Q, Liu Quan Q et al.

The metabolic landscape of breast cancer is intricately associated with patient outcomes, with metabolic reprogramming serving as a crucial determinant. Nevertheless, the precise relationship between AKR1B10, a metabolic enzyme, and metabolism has remained elusive. The expression and clinical relevance of AKR1B10 in breast cancer tissues and cell lines were examined through a comprehensive approach that integrated bioinformatics, metabolomics, quantitative real-time polymerase chain reaction (qRT-PCR), and western blot analysis. The impact of AKR1B10 on breast cancer metabolism was investigated through the implementation of gain- and loss-of-function experiments, conducted both in vitro and in vivo. This was complemented by the utilization of mass spectrometry and glucose metabolism analysis. To elucidate the potential underlying mechanisms, co-immunoprecipitation (Co-IP), RNA sequencing (RNA-seq), and chromatin immunoprecipitation sequencing (ChIP-seq) techniques were employed. This study demonstrated that aberrant overexpression of AKR1B10 is essential for tumor cell proliferation and the activation of the Warburg effect in breast cancer. The findings revealed that AKR1B10 functions as a bridge linking the insulin-like growth factor 2 receptor (IGF2R) and phosphoglycerate kinase 1 (PGK1), resulting in the phosphorylation of PGK1 at Y324 through IGF2R. This activation ultimately enhanced the Warburg effect and lactate production, promoted dynamic lactylation of H4K12 (H4K12la, histone H4 lysine 12 lactylation), and led to the transcriptional activation of mTOR, which promoted breast cell proliferation. The present study has identified a novel mechanism involving the IGF2R-AKR1B10-PGK1-H4K12la-mTOR signaling axis, which has been demonstrated to exacerbate the Warburg effect and promote tumorigenesis in breast cancer. AKR1B10 knockdown or the combination of the AKR1B10 inhibitor oleanolic acid (OA) with the glycolysis inhibitor D-arabino-2-deoxyhexose (2-DG) were found to inhibit this axis, thereby reprogramming the metabolism of breast cancer cells and suppressing proliferation. These findings underscore the critical role of AKR1B10 in reprogramming breast cancer cells' metabolism, and provides a rationale for the development of a novel therapeutic strategy for the treatment of breast cancer.

PMID 43053102
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多lysine salicylate